Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P21
Within normal range
vs 3Y Ago
-3.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-89.79%
2024-117.66%
2023-14.32%
202227.62%
2021-17.90%
2020-84.39%
201962.99%
2018-16.42%
20175.68%
201622.61%